ID   CP1A2_HUMAN             Reviewed;         515 AA.
AC   P05177; Q16754; Q6NWU5; Q9BXX7; Q9UK49;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Cytochrome P450 1A2;
DE            EC=1.14.14.1 {ECO:0000269|PubMed:21576599};
DE   AltName: Full=CYPIA2;
DE   AltName: Full=Cholesterol 25-hydroxylase {ECO:0000305|PubMed:21576599};
DE   AltName: Full=Cytochrome P(3)450;
DE   AltName: Full=Cytochrome P450 4;
DE   AltName: Full=Cytochrome P450-P3;
GN   Name=CYP1A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3755823; DOI=10.1093/nar/14.16.6773;
RA   Jaiswal A.K., Nebert D.W., Gonzalez F.J.;
RT   "Human P3(450): cDNA and complete amino acid sequence.";
RL   Nucleic Acids Res. 14:6773-6774(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=3462722; DOI=10.1073/pnas.83.18.6731;
RA   Quattrochi L.C., Pendurthi U.R., Okino S.T., Potenza C., Tukey R.H.;
RT   "Human cytochrome P-450 4 mRNA and gene: part of a multigene family
RT   that contains Alu sequences in its mRNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6731-6735(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2575218; DOI=10.1210/mend-3-9-1399;
RA   Ikeya K., Jaiswal A.K., Owens R.A., Jones J.E., Nebert D.W.,
RA   Kimura S.;
RT   "Human CYP1A2: sequence, gene structure, comparison with the mouse and
RT   rat orthologous gene, and differences in liver 1A2 mRNA expression.";
RL   Mol. Endocrinol. 3:1399-1408(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3681487;
RA   Jaiswal A.K., Nebert D.W., McBride O.W., Gonzalez F.J.;
RT   "Human P(3)450: cDNA and complete protein sequence, repetitive Alu
RT   sequences in the 3' nontranslated region, and localization of gene to
RT   chromosome 15.";
RL   J. Exp. Pathol. 3:1-17(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT VAL-314.
RC   TISSUE=Liver;
RA   Zhuge J., Qian Y., Xie H., Yu Y.;
RT   "Sequence of a new human cytochrome P450-1A2 cDNA.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11207026; DOI=10.1097/00008571-200102000-00001;
RA   Corchero J., Pimprale S., Kimura S., Gonzalez F.J.;
RT   "Organization of the CYP1A cluster on human chromosome 15:
RT   implications for gene regulation.";
RL   Pharmacogenetics 11:1-6(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-73; ASN-104;
RP   PHE-111; VAL-205; TRP-281 AND ILE-438.
RG   NIEHS SNPs program;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-19.
RX   PubMed=3517618;
RA   Wrighton S.A., Campanile C., Thomas P.E., Maines S.L., Watkins P.B.,
RA   Parker G., Mendez-Picon G., Haniu M., Shively J.E., Levin W.,
RA   Guzelian P.S.;
RT   "Identification of a human liver cytochrome P-450 homologous to the
RT   major isosafrole-inducible cytochrome P-450 in the rat.";
RL   Mol. Pharmacol. 29:405-410(1986).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 295-485.
RC   TISSUE=Liver;
RX   PubMed=3000715; DOI=10.1089/dna.1985.4.395;
RA   Quattrochi L.C., Okino S.T., Pendurthi U.R., Tukey R.H.;
RT   "Cloning and isolation of human cytochrome P-450 cDNAs homologous to
RT   dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.";
RL   DNA 4:395-400(1985).
RN   [11]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND CHARACTERIZATION OF
RP   VARIANTS ASN-348; PHE-386; TYR-406 AND TRP-431.
RX   PubMed=14725854; DOI=10.1016/j.abb.2003.11.019;
RA   Zhou H., Josephy P.D., Kim D., Guengerich F.P.;
RT   "Functional characterization of four allelic variants of human
RT   cytochrome P450 1A2.";
RL   Arch. Biochem. Biophys. 422:23-30(2004).
RN   [12]
RP   CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=21576599; DOI=10.1194/jlr.M014084;
RA   Honda A., Miyazaki T., Ikegami T., Iwamoto J., Maeda T., Hirayama T.,
RA   Saito Y., Teramoto T., Matsuzaki Y.;
RT   "Cholesterol 25-hydroxylation activity of CYP3A.";
RL   J. Lipid Res. 52:1509-1516(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 27-515 IN COMPLEX WITH THE
RP   INHIBITOR ALPHA-NAPHTHOFLAVONE AND HEME.
RX   PubMed=17311915; DOI=10.1074/jbc.M611692200;
RA   Sansen S., Yano J.K., Reynald R.L., Schoch G.A., Griffin K.J.,
RA   Stout C.D., Johnson E.F.;
RT   "Adaptations for the oxidation of polycyclic aromatic hydrocarbons
RT   exhibited by the structure of human P450 1A2.";
RL   J. Biol. Chem. 282:14348-14355(2007).
RN   [15]
RP   VARIANT LEU-21.
RX   PubMed=9884316;
RA   Huang J.D., Guo W.C., Lai M.D., Guo Y.L., Lambert G.H.;
RT   "Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in
RT   Chinese.";
RL   Drug Metab. Dispos. 27:98-101(1999).
RN   [16]
RP   VARIANTS ASN-348; PHE-386; TYR-406 AND TRP-431.
RX   PubMed=11295848; DOI=10.1002/humu.49;
RA   Chevalier D., Cauffiez C., Allorge D., Lo-Guidice J.-M., Lhermitte M.,
RA   Lafitte J.-J., Broly F.;
RT   "Five novel natural allelic variants-951A->C, 1042G->A (D348N),
RT   1156A->T (I386F), 1217G->A (C406Y) and 1291C->T (C431Y)-of the human
RT   CYP1A2 gene in a French Caucasian population.";
RL   Hum. Mutat. 17:355-356(2001).
RN   [17]
RP   VARIANTS MET-83; GLN-168; LEU-186; CYS-212; SER-299 AND ILE-438.
RX   PubMed=14563787; DOI=10.1124/jpet.103.055798;
RA   Murayama N., Soyama A., Saito Y., Nakajima Y., Komamura K., Ueno K.,
RA   Kamakura S., Kitakaze M., Kimura H., Goto Y., Saitoh O., Katoh M.,
RA   Ohnuma T., Kawai M., Sugai K., Ohtsuki T., Suzuki C., Minami N.,
RA   Ozawa S., Sawada J.;
RT   "Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic
RT   activities of the naturally occurring variant enzymes.";
RL   J. Pharmacol. Exp. Ther. 308:300-306(2004).
RN   [18]
RP   VARIANTS CYS-18; ARG-298; VAL-314 AND TRP-431.
RX   PubMed=15469410; DOI=10.1517/14622416.5.7.895;
RA   Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
RA   McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
RT   "Genetic variation in eleven phase I drug metabolism genes in an
RT   ethnically diverse population.";
RL   Pharmacogenomics 5:895-931(2004).
RN   [19]
RP   VARIANTS ARG-42; GLN-377 AND HIS-456.
RX   PubMed=15770072; DOI=10.2133/dmpk.20.24;
RA   Soyama A., Saito Y., Hanioka N., Maekawa K., Komamura K., Kamakura S.,
RA   Kitakaze M., Tomoike H., Ueno K., Goto Y., Kimura H., Katoh M.,
RA   Sugai K., Saitoh O., Kawai M., Ohnuma T., Ohtsuki T., Suzuki C.,
RA   Minami N., Kamatani N., Ozawa S., Sawada J.;
RT   "Single nucleotide polymorphisms and haplotypes of CYP1A2 in a
RT   Japanese population.";
RL   Drug Metab. Pharmacokinet. 20:24-33(2005).
RN   [20]
RP   VARIANT CYS-18.
RX   PubMed=15643613; DOI=10.1002/humu.20134;
RA   Jiang Z., Dalton T.P., Jin L., Wang B., Tsuneoka Y., Shertzer H.G.,
RA   Deka R., Nebert D.W.;
RT   "Toward the evaluation of function in genetic variability:
RT   characterizing human SNP frequencies and establishing BAC-transgenic
RT   mice carrying the human CYP1A1_CYP1A2 locus.";
RL   Hum. Mutat. 25:196-206(2005).
RN   [21]
RP   EFFECT OF CAFFEINE METABOLISM ON RISKS OF MYOCARDIAL INFARCTION.
RX   PubMed=16522833; DOI=10.1001/jama.295.10.1135;
RA   Cornelis M.C., El-Sohemy A., Kabagambe E.K., Campos H.;
RT   "Coffee, CYP1A2 genotype, and risk of myocardial infarction.";
RL   JAMA 295:1135-1141(2006).
CC   -!- FUNCTION: Cytochromes P450 are a group of heme-thiolate
CC       monooxygenases. In liver microsomes, this enzyme is involved in an
CC       NADPH-dependent electron transport pathway. It oxidizes a variety
CC       of structurally unrelated compounds, including steroids, fatty
CC       acids, and xenobiotics. Most active in catalyzing 2-hydroxylation.
CC       Caffeine is metabolized primarily by cytochrome CYP1A2 in the
CC       liver through an initial N3-demethylation. Also acts in the
CC       metabolism of aflatoxin B1 and acetaminophen. Participates in the
CC       bioactivation of carcinogenic aromatic and heterocyclic amines.
CC       Catalizes the N-hydroxylation of heterocyclic amines and the O-
CC       deethylation of phenacetin. {ECO:0000269|PubMed:14725854}.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC       {ECO:0000269|PubMed:21576599}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4 uM for 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole
CC         {ECO:0000269|PubMed:14725854};
CC         KM=21 uM for 2-amino-3-methylimidazo[4,5-f]quinoline
CC         {ECO:0000269|PubMed:14725854};
CC         KM=26 uM for 2-amino-2,4-dimethylimidazo[4,5-f]quinoline
CC         {ECO:0000269|PubMed:14725854};
CC         KM=27 uM for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
CC         {ECO:0000269|PubMed:14725854};
CC         KM=71 uM for 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
CC         {ECO:0000269|PubMed:14725854};
CC         KM=25 uM for phenacetin {ECO:0000269|PubMed:14725854};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane
CC       {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05177-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05177-2; Sequence=VSP_017123;
CC   -!- TISSUE SPECIFICITY: Liver.
CC   -!- INDUCTION: By nicotine, omeprazole, phenobarbital, primidone and
CC       rifampicin.
CC   -!- POLYMORPHISM: The CYP1A2*1F allele which is quite common (40 to
CC       50%) is due to a substitution of a base in the non-coding region
CC       of the CYP1A2 gene and has the effect of decreasing the enzyme
CC       inducibility. Individuals who are homozygous for the CYP1A2*1F
CC       allele are 'slow' caffeine metabolizers. Thus for these individual
CC       increased intake of caffeine seems to be associated with a
CC       concomitant increase in the risk of non-fatal myocardial
CC       infraction (MI).
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP1A2 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp1a2.htm";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp1a2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z00036; CAA77335.1; -; mRNA.
DR   EMBL; L00389; AAA35738.1; -; Genomic_DNA.
DR   EMBL; L00384; AAA35738.1; JOINED; Genomic_DNA.
DR   EMBL; L00385; AAA35738.1; JOINED; Genomic_DNA.
DR   EMBL; L00386; AAA35738.1; JOINED; Genomic_DNA.
DR   EMBL; L00388; AAA35738.1; JOINED; Genomic_DNA.
DR   EMBL; L00387; AAA35738.1; JOINED; Genomic_DNA.
DR   EMBL; M31667; AAA52163.1; -; Genomic_DNA.
DR   EMBL; M31664; AAA52163.1; JOINED; Genomic_DNA.
DR   EMBL; M31665; AAA52163.1; JOINED; Genomic_DNA.
DR   EMBL; M31666; AAA52163.1; JOINED; Genomic_DNA.
DR   EMBL; M12078; AAA52154.1; -; mRNA.
DR   EMBL; AF182274; AAF13599.1; -; mRNA.
DR   EMBL; AF253322; AAK25728.1; -; Genomic_DNA.
DR   EMBL; DQ022432; AAY26399.1; -; Genomic_DNA.
DR   EMBL; BC067424; AAH67424.1; -; mRNA.
DR   EMBL; BC067425; AAH67425.1; -; mRNA.
DR   EMBL; BC067426; AAH67426.1; -; mRNA.
DR   EMBL; BC067427; AAH67427.1; -; mRNA.
DR   EMBL; BC067428; AAH67428.1; -; mRNA.
DR   EMBL; M55053; AAA52146.1; -; mRNA.
DR   CCDS; CCDS32293.1; -. [P05177-2]
DR   PIR; S16718; O4HU4.
DR   RefSeq; NP_000752.2; NM_000761.4. [P05177-2]
DR   UniGene; Hs.1361; -.
DR   PDB; 2HI4; X-ray; 1.95 A; A=27-515.
DR   PDBsum; 2HI4; -.
DR   ProteinModelPortal; P05177; -.
DR   SMR; P05177; -.
DR   BioGrid; 107924; 7.
DR   STRING; 9606.ENSP00000342007; -.
DR   BindingDB; P05177; -.
DR   ChEMBL; CHEMBL3356; -.
DR   DrugBank; DB07453; 2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE.
DR   DrugBank; DB05812; Abiraterone.
DR   DrugBank; DB01418; Acenocoumarol.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB06594; Agomelatine.
DR   DrugBank; DB00518; Albendazole.
DR   DrugBank; DB00523; Alitretinoin.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB00969; Alosetron.
DR   DrugBank; DB00357; Aminoglutethimide.
DR   DrugBank; DB01424; Aminophenazone.
DR   DrugBank; DB01223; Aminophylline.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB00261; Anagrelide.
DR   DrugBank; DB01217; Anastrozole.
DR   DrugBank; DB01435; Antipyrine.
DR   DrugBank; DB06605; Apixaban.
DR   DrugBank; DB00673; Aprepitant.
DR   DrugBank; DB06413; Armodafinil.
DR   DrugBank; DB06216; Asenapine.
DR   DrugBank; DB00572; Atropine.
DR   DrugBank; DB06626; Axitinib.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB00207; Azithromycin.
DR   DrugBank; DB06769; Bendamustine.
DR   DrugBank; DB06770; Benzyl alcohol.
DR   DrugBank; DB06732; beta-Naphthoflavone.
DR   DrugBank; DB00195; Betaxolol.
DR   DrugBank; DB00188; Bortezomib.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB01200; Bromocriptine.
DR   DrugBank; DB00297; Bupivacaine.
DR   DrugBank; DB00921; Buprenorphine.
DR   DrugBank; DB01156; Bupropion.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB06774; Capsaicin.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB00262; Carmustine.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00356; Chlorzoxazone.
DR   DrugBank; DB01166; Cilostazol.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB01012; Cinacalcet.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB00537; Ciprofloxacin.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00215; Citalopram.
DR   DrugBank; DB01211; Clarithromycin.
DR   DrugBank; DB01407; Clenbuterol.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB01013; Clobetasol propionate.
DR   DrugBank; DB00882; Clomifene.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00575; Clonidine.
DR   DrugBank; DB00758; Clopidogrel.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB00924; Cyclobenzaprine.
DR   DrugBank; DB00851; Dacarbazine.
DR   DrugBank; DB04816; Dantron.
DR   DrugBank; DB06292; Dapagliflozin.
DR   DrugBank; DB01254; Dasatinib.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB00705; Delavirdine.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB00967; Desloratadine.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB00633; Dexmedetomidine.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00917; Dinoprostone.
DR   DrugBank; DB01075; Diphenhydramine.
DR   DrugBank; DB01184; Domperidone.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB00476; Duloxetine.
DR   DrugBank; DB00974; Edetic Acid.
DR   DrugBank; DB00625; Efavirenz.
DR   DrugBank; DB06210; Eltrombopag.
DR   DrugBank; DB00467; Enoxacin.
DR   DrugBank; DB00668; Epinephrine.
DR   DrugBank; DB00696; Ergotamine.
DR   DrugBank; DB00530; Erlotinib.
DR   DrugBank; DB00199; Erythromycin.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB04574; Estrone sulfate.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB01628; Etoricoxib.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00544; Fluorouracil.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB00623; Fluphenazine.
DR   DrugBank; DB00499; Flutamide.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00998; Frovatriptan.
DR   DrugBank; DB01241; Gemfibrozil.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB00365; Grepafloxacin.
DR   DrugBank; DB00400; Griseofulvin.
DR   DrugBank; DB05708; GTS-21.
DR   DrugBank; DB00629; Guanabenz.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB01094; Hesperetin.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB04946; Iloperidone.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB00724; Imiquimod.
DR   DrugBank; DB01306; Insulin Aspart.
DR   DrugBank; DB09456; Insulin Beef.
DR   DrugBank; DB01307; Insulin Detemir.
DR   DrugBank; DB00047; Insulin Glargine.
DR   DrugBank; DB01309; Insulin Glulisine.
DR   DrugBank; DB00030; Insulin Human.
DR   DrugBank; DB00046; Insulin Lispro.
DR   DrugBank; DB00071; Insulin Pork.
DR   DrugBank; DB01029; Irbesartan.
DR   DrugBank; DB00951; Isoniazid.
DR   DrugBank; DB09570; Ixazomib.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB01097; Leflunomide.
DR   DrugBank; DB01002; Levobupivacaine.
DR   DrugBank; DB01137; Levofloxacin.
DR   DrugBank; DB00281; Lidocaine.
DR   DrugBank; DB00978; Lomefloxacin.
DR   DrugBank; DB01601; Lopinavir.
DR   DrugBank; DB04871; Lorcaserin.
DR   DrugBank; DB00678; Losartan.
DR   DrugBank; DB01283; Lumiracoxib.
DR   DrugBank; DB00772; Malathion.
DR   DrugBank; DB00934; Maprotiline.
DR   DrugBank; DB00737; Meclizine.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB00532; Mephenytoin.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB00763; Methimazole.
DR   DrugBank; DB01403; Methotrimeprazine.
DR   DrugBank; DB00553; Methoxsalen.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00379; Mexiletine.
DR   DrugBank; DB06148; Mianserin.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01171; Moclobemide.
DR   DrugBank; DB00745; Modafinil.
DR   DrugBank; DB00461; Nabumetone.
DR   DrugBank; DB00607; Nafcillin.
DR   DrugBank; DB00788; Naproxen.
DR   DrugBank; DB00220; Nelfinavir.
DR   DrugBank; DB00238; Nevirapine.
DR   DrugBank; DB06803; Niclosamide.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB00401; Nisoldipine.
DR   DrugBank; DB00435; Nitric Oxide.
DR   DrugBank; DB00325; Nitroprusside.
DR   DrugBank; DB00368; Norepinephrine.
DR   DrugBank; DB01059; Norfloxacin.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB01165; Ofloxacin.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB00904; Ondansetron.
DR   DrugBank; DB09330; Osimertinib.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB01303; Oxtriphylline.
DR   DrugBank; DB06412; Oxymetholone.
DR   DrugBank; DB00377; Palonosetron.
DR   DrugBank; DB00213; Pantoprazole.
DR   DrugBank; DB06589; Pazopanib.
DR   DrugBank; DB00487; Pefloxacin.
DR   DrugBank; DB00738; Pentamidine.
DR   DrugBank; DB00806; Pentoxifylline.
DR   DrugBank; DB00850; Perphenazine.
DR   DrugBank; DB03783; Phenacetin.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00191; Phentermine.
DR   DrugBank; DB00388; Phenylephrine.
DR   DrugBank; DB00397; Phenylpropanolamine.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB01621; Pipotiazine.
DR   DrugBank; DB08910; Pomalidomide.
DR   DrugBank; DB01058; Praziquantel.
DR   DrugBank; DB01087; Primaquine.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB01131; Proguanil.
DR   DrugBank; DB00420; Promazine.
DR   DrugBank; DB01182; Propafenone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00571; Propranolol.
DR   DrugBank; DB00339; Pyrazinamide.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB01129; Rabeprazole.
DR   DrugBank; DB00980; Ramelteon.
DR   DrugBank; DB00863; Ranitidine.
DR   DrugBank; DB01367; Rasagiline.
DR   DrugBank; DB02709; Resveratrol.
DR   DrugBank; DB00615; Rifabutin.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB08864; Rilpivirine.
DR   DrugBank; DB00740; Riluzole.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB00953; Rizatriptan.
DR   DrugBank; DB00533; Rofecoxib.
DR   DrugBank; DB00268; Ropinirole.
DR   DrugBank; DB00296; Ropivacaine.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB05271; Rotigotine.
DR   DrugBank; DB00778; Roxithromycin.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB06290; Simeprevir.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB00428; Streptozocin.
DR   DrugBank; DB06820; Sulconazole.
DR   DrugBank; DB00605; Sulindac.
DR   DrugBank; DB00382; Tacrine.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00976; Telithromycin.
DR   DrugBank; DB01405; Temafloxacin.
DR   DrugBank; DB00300; Tenofovir.
DR   DrugBank; DB00857; Terbinafine.
DR   DrugBank; DB01041; Thalidomide.
DR   DrugBank; DB01412; Theobromine.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB00730; Thiabendazole.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB01623; Thiothixene.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB01007; Tioconazole.
DR   DrugBank; DB00697; Tizanidine.
DR   DrugBank; DB01056; Tocainide.
DR   DrugBank; DB00539; Toremifene.
DR   DrugBank; DB00752; Tranylcypromine.
DR   DrugBank; DB00384; Triamterene.
DR   DrugBank; DB00831; Trifluoperazine.
DR   DrugBank; DB08867; Ulipristal.
DR   DrugBank; DB00313; Valproic Acid.
DR   DrugBank; DB08881; Vemurafenib.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB00682; Warfarin.
DR   DrugBank; DB00549; Zafirlukast.
DR   DrugBank; DB00744; Zileuton.
DR   DrugBank; DB00246; Ziprasidone.
DR   DrugBank; DB00315; Zolmitriptan.
DR   DrugBank; DB00425; Zolpidem.
DR   GuidetoPHARMACOLOGY; 1319; -.
DR   SwissLipids; SLP:000001202; -.
DR   iPTMnet; P05177; -.
DR   PhosphoSitePlus; P05177; -.
DR   BioMuta; CYP1A2; -.
DR   DMDM; 117144; -.
DR   MaxQB; P05177; -.
DR   PaxDb; P05177; -.
DR   PeptideAtlas; P05177; -.
DR   PRIDE; P05177; -.
DR   Ensembl; ENST00000343932; ENSP00000342007; ENSG00000140505. [P05177-2]
DR   GeneID; 1544; -.
DR   KEGG; hsa:1544; -.
DR   UCSC; uc002ayr.2; human. [P05177-1]
DR   CTD; 1544; -.
DR   DisGeNET; 1544; -.
DR   GeneCards; CYP1A2; -.
DR   HGNC; HGNC:2596; CYP1A2.
DR   HPA; CAB016531; -.
DR   MalaCards; CYP1A2; -.
DR   MIM; 108330; gene.
DR   MIM; 124060; gene+phenotype.
DR   neXtProt; NX_P05177; -.
DR   OpenTargets; ENSG00000140505; -.
DR   Orphanet; 284121; Toxixity or absent response to clozapine.
DR   PharmGKB; PA27093; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118992; -.
DR   HOVERGEN; HBG106944; -.
DR   InParanoid; P05177; -.
DR   KO; K07409; -.
DR   OMA; KCCVFVN; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P05177; -.
DR   TreeFam; TF105095; -.
DR   BioCyc; MetaCyc:HS06728-MONOMER; -.
DR   BRENDA; 1.14.14.1; 2681.
DR   BRENDA; 1.14.99.38; 2681.
DR   Reactome; R-HSA-156581; Methylation.
DR   Reactome; R-HSA-211957; Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2.
DR   Reactome; R-HSA-2142670; Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET).
DR   Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
DR   Reactome; R-HSA-5423646; Aflatoxin activation and detoxification.
DR   SABIO-RK; P05177; -.
DR   EvolutionaryTrace; P05177; -.
DR   GeneWiki; CYP1A2; -.
DR   GenomeRNAi; 1544; -.
DR   PRO; PR:P05177; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140505; -.
DR   CleanEx; HS_CYP1A2; -.
DR   Genevisible; P05177; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL.
DR   GO; GO:0032451; F:demethylase activity; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL.
DR   GO; GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IMP:UniProtKB.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0009820; P:alkaloid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0045333; P:cellular respiration; IEA:Ensembl.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
DR   GO; GO:0018894; P:dibenzo-p-dioxin metabolic process; IEA:Ensembl.
DR   GO; GO:0042737; P:drug catabolic process; IMP:BHF-UCL.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome.
DR   GO; GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL.
DR   GO; GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL.
DR   GO; GO:0050665; P:hydrogen peroxide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0032259; P:methylation; TAS:Reactome.
DR   GO; GO:0032787; P:monocarboxylic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0071615; P:oxidative deethylation; IDA:BHF-UCL.
DR   GO; GO:0070989; P:oxidative demethylation; IDA:BHF-UCL.
DR   GO; GO:0006778; P:porphyrin-containing compound metabolic process; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0006706; P:steroid catabolic process; IMP:BHF-UCL.
DR   GO; GO:0009403; P:toxin biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR008066; Cyt_P450_E_grp-I_CYP1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR01683; EP450ICYP1A.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Endoplasmic reticulum; Glycoprotein; Heme;
KW   Iron; Lipid metabolism; Membrane; Metal-binding; Microsome;
KW   Monooxygenase; Oxidoreductase; Polymorphism; Reference proteome;
KW   Steroid metabolism; Sterol metabolism.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:3517618}.
FT   CHAIN         2    515       Cytochrome P450 1A2.
FT                                /FTId=PRO_0000051651.
FT   METAL       458    458       Iron (heme axial ligand).
FT   BINDING     226    226       Substrate. {ECO:0000305}.
FT   CARBOHYD     69     69       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   VAR_SEQ     510    510       R -> RL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_017123.
FT   VARIANT      18     18       S -> C (in dbSNP:rs17861152).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15643613}.
FT                                /FTId=VAR_023196.
FT   VARIANT      21     21       F -> L (in allele CYP1A2*2;
FT                                dbSNP:rs56160784).
FT                                {ECO:0000269|PubMed:9884316}.
FT                                /FTId=VAR_008349.
FT   VARIANT      42     42       P -> R (in allele CYP1A2*15).
FT                                {ECO:0000269|PubMed:15770072}.
FT                                /FTId=VAR_025182.
FT   VARIANT      73     73       G -> R (in dbSNP:rs45565238).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_025183.
FT   VARIANT      83     83       T -> M (in allele CYP1A2*9).
FT                                {ECO:0000269|PubMed:14563787}.
FT                                /FTId=VAR_020848.
FT   VARIANT     104    104       D -> N (in dbSNP:rs34067076).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_025184.
FT   VARIANT     111    111       L -> F (in dbSNP:rs45442197).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_025185.
FT   VARIANT     168    168       E -> Q (in allele CYP1A2*10).
FT                                {ECO:0000269|PubMed:14563787}.
FT                                /FTId=VAR_020849.
FT   VARIANT     186    186       F -> L (in allele CYP1A2*11; drastic
FT                                reduction in O-deethylation of phenacetin
FT                                and 7-ethoxyresorufin; has a Vmax of
FT                                approximately 5% of that of the wild-type
FT                                and 5-fold lower Km value).
FT                                {ECO:0000269|PubMed:14563787}.
FT                                /FTId=VAR_020850.
FT   VARIANT     205    205       F -> V (in dbSNP:rs45540640).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_025186.
FT   VARIANT     212    212       S -> C (in allele CYP1A2*12).
FT                                {ECO:0000269|PubMed:14563787}.
FT                                /FTId=VAR_020851.
FT   VARIANT     281    281       R -> W (in dbSNP:rs45468096).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_025187.
FT   VARIANT     298    298       S -> R (in dbSNP:rs17861157).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024709.
FT   VARIANT     299    299       G -> S (in allele CYP1A2*13;
FT                                dbSNP:rs35796837).
FT                                {ECO:0000269|PubMed:14563787}.
FT                                /FTId=VAR_020852.
FT   VARIANT     314    314       I -> V (in dbSNP:rs28399418).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_024710.
FT   VARIANT     348    348       D -> N (in allele CYP1A2*3; increases N-
FT                                hydroxylation activity of heterocyclic
FT                                amines; reduces phenacetin O-deethylation
FT                                activity; dbSNP:rs56276455).
FT                                {ECO:0000269|PubMed:11295848,
FT                                ECO:0000269|PubMed:14725854}.
FT                                /FTId=VAR_020793.
FT   VARIANT     377    377       R -> Q (in allele CYP1A2*16).
FT                                {ECO:0000269|PubMed:15770072}.
FT                                /FTId=VAR_025188.
FT   VARIANT     386    386       I -> F (in allele CYP1A2*4; increases
FT                                catalytic efficiency of N-hydroxylation
FT                                towards some heterocyclic amines and
FT                                reduces towards others; reduces catalytic
FT                                efficiency of phenacetin O-deethylation
FT                                due to a high decrease in the affinity
FT                                for phenacetin).
FT                                {ECO:0000269|PubMed:11295848,
FT                                ECO:0000269|PubMed:14725854}.
FT                                /FTId=VAR_020794.
FT   VARIANT     406    406       C -> Y (in allele CYP1A2*5; increases N-
FT                                hydroxylation activity of heterocyclic
FT                                amines; reduces catalytic efficiency of
FT                                phenacetin O-deethylation;
FT                                dbSNP:rs55889066).
FT                                {ECO:0000269|PubMed:11295848,
FT                                ECO:0000269|PubMed:14725854}.
FT                                /FTId=VAR_020795.
FT   VARIANT     431    431       R -> W (in allele CYP1A2*6; not detected
FT                                when expressed in heterologous system as
FT                                it may be critical for maintenance of
FT                                protein tertiary structure;
FT                                dbSNP:rs28399424).
FT                                {ECO:0000269|PubMed:11295848,
FT                                ECO:0000269|PubMed:14725854,
FT                                ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_020796.
FT   VARIANT     438    438       T -> I (in allele CYP1A2*14;
FT                                dbSNP:rs45486893).
FT                                {ECO:0000269|PubMed:14563787,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_020853.
FT   VARIANT     456    456       R -> H (in allele CYP1A2*8).
FT                                {ECO:0000269|PubMed:15770072}.
FT                                /FTId=VAR_025189.
FT   VARIANT     457    457       R -> W (in dbSNP:rs34151816).
FT                                /FTId=VAR_055563.
FT   CONFLICT     79     79       R -> S (in Ref. 2; AAA35738).
FT                                {ECO:0000305}.
FT   CONFLICT     81     81       G -> D (in Ref. 8; AAH67427).
FT                                {ECO:0000305}.
FT   CONFLICT    170    170       K -> M (in Ref. 5; AAF13599).
FT                                {ECO:0000305}.
FT   CONFLICT    311    311       V -> L (in Ref. 10; AAA52154).
FT                                {ECO:0000305}.
FT   CONFLICT    450    451       LF -> MLV (in Ref. 10; AAA52154).
FT                                {ECO:0000305}.
FT   CONFLICT    492    492       T -> I (in Ref. 5; AAF13599).
FT                                {ECO:0000305}.
FT   CONFLICT    511    511       R -> LP (in Ref. 2; AAA35738).
FT                                {ECO:0000305}.
FT   TURN         49     51       {ECO:0000244|PDB:2HI4}.
FT   HELIX        54     57       {ECO:0000244|PDB:2HI4}.
FT   HELIX        61     72       {ECO:0000244|PDB:2HI4}.
FT   STRAND       74     80       {ECO:0000244|PDB:2HI4}.
FT   STRAND       83     88       {ECO:0000244|PDB:2HI4}.
FT   HELIX        91     98       {ECO:0000244|PDB:2HI4}.
FT   TURN         99    101       {ECO:0000244|PDB:2HI4}.
FT   HELIX       102    104       {ECO:0000244|PDB:2HI4}.
FT   HELIX       112    115       {ECO:0000244|PDB:2HI4}.
FT   TURN        123    125       {ECO:0000244|PDB:2HI4}.
FT   HELIX       131    146       {ECO:0000244|PDB:2HI4}.
FT   TURN        147    149       {ECO:0000244|PDB:2HI4}.
FT   HELIX       160    181       {ECO:0000244|PDB:2HI4}.
FT   HELIX       188    205       {ECO:0000244|PDB:2HI4}.
FT   HELIX       206    208       {ECO:0000244|PDB:2HI4}.
FT   HELIX       214    220       {ECO:0000244|PDB:2HI4}.
FT   HELIX       221    223       {ECO:0000244|PDB:2HI4}.
FT   HELIX       224    227       {ECO:0000244|PDB:2HI4}.
FT   HELIX       235    237       {ECO:0000244|PDB:2HI4}.
FT   HELIX       240    244       {ECO:0000244|PDB:2HI4}.
FT   HELIX       248    273       {ECO:0000244|PDB:2HI4}.
FT   HELIX       283    293       {ECO:0000244|PDB:2HI4}.
FT   HELIX       305    308       {ECO:0000244|PDB:2HI4}.
FT   HELIX       310    335       {ECO:0000244|PDB:2HI4}.
FT   HELIX       337    350       {ECO:0000244|PDB:2HI4}.
FT   TURN        351    353       {ECO:0000244|PDB:2HI4}.
FT   HELIX       359    361       {ECO:0000244|PDB:2HI4}.
FT   HELIX       366    379       {ECO:0000244|PDB:2HI4}.
FT   STRAND      394    396       {ECO:0000244|PDB:2HI4}.
FT   STRAND      399    401       {ECO:0000244|PDB:2HI4}.
FT   STRAND      406    410       {ECO:0000244|PDB:2HI4}.
FT   HELIX       411    416       {ECO:0000244|PDB:2HI4}.
FT   TURN        418    420       {ECO:0000244|PDB:2HI4}.
FT   HELIX       429    432       {ECO:0000244|PDB:2HI4}.
FT   STRAND      437    440       {ECO:0000244|PDB:2HI4}.
FT   HELIX       442    445       {ECO:0000244|PDB:2HI4}.
FT   HELIX       454    456       {ECO:0000244|PDB:2HI4}.
FT   HELIX       461    478       {ECO:0000244|PDB:2HI4}.
FT   STRAND      480    482       {ECO:0000244|PDB:2HI4}.
FT   STRAND      496    498       {ECO:0000244|PDB:2HI4}.
FT   STRAND      507    510       {ECO:0000244|PDB:2HI4}.
SQ   SEQUENCE   515 AA;  58294 MW;  23AEFEEBDF6806AB CRC64;
     MALSQSVPFS ATELLLASAI FCLVFWVLKG LRPRVPKGLK SPPEPWGWPL LGHVLTLGKN
     PHLALSRMSQ RYGDVLQIRI GSTPVLVLSR LDTIRQALVR QGDDFKGRPD LYTSTLITDG
     QSLTFSTDSG PVWAARRRLA QNALNTFSIA SDPASSSSCY LEEHVSKEAK ALISRLQELM
     AGPGHFDPYN QVVVSVANVI GAMCFGQHFP ESSDEMLSLV KNTHEFVETA SSGNPLDFFP
     ILRYLPNPAL QRFKAFNQRF LWFLQKTVQE HYQDFDKNSV RDITGALFKH SKKGPRASGN
     LIPQEKIVNL VNDIFGAGFD TVTTAISWSL MYLVTKPEIQ RKIQKELDTV IGRERRPRLS
     DRPQLPYLEA FILETFRHSS FLPFTIPHST TRDTTLNGFY IPKKCCVFVN QWQVNHDPEL
     WEDPSEFRPE RFLTADGTAI NKPLSEKMML FGMGKRRCIG EVLAKWEIFL FLAILLQQLE
     FSVPPGVKVD LTPIYGLTMK HARCEHVQAR RFSIN
//
